MedPath

Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome

Phase 1
Recruiting
Conditions
Polycystic Ovary Syndrome
Interventions
Drug: Bushen Huatan Decoction
Drug: Placebo
Registration Number
NCT05976308
Lead Sponsor
Jiangxi University of Traditional Chinese Medicine
Brief Summary

Polycystic ovary syndrome (PCOS) is a common reproductive disease associated with endocrine and metabolic disorders. Some studies have shown that Chinese herbal medicine is beneficial for PCOS, but the efficacy of Chinese herbal medicine in the treatment of PCOS is not clear, because the quantity of pre-clinical data was limited and the quality of clinical evidence was variable. Therefore, this randomized double-blind placebo-controlled trial aim to evaluate the efficacy of Chinese herbal medicine (Bushen Huatan Decoction) in women with PCOS.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
68
Inclusion Criteria
  1. The diagnosis of PCOS is based on the Rotterdam criteria.
  2. Meet the syndrome differentiation standard of kidney-yang deficiency with phlegm-dampness and blood stasis in TCM theory.
  3. women aged 18-40 years without fertility requirements.
  4. A willingness to undergo this treatment plan.
Exclusion Criteria
  1. Hyperprolactinemia (2 times serum prolactin levels of more than 25 ng/ml at least one week apart).
  2. Diminished ovarian reserve, FSH (follicle-stimulating hormone) level more than 10 IU/L.
  3. Abnormal thyroid function, TSH (thyroid stimulating hormone) level less than 0.2 mIU/mL or more than 5.5 mIU/mL.
  4. Suspected Cushing's syndrome.
  5. Adrenal or ovarian tumors secreting androgen.
  6. Poorly controlled type II diabetes.
  7. Pregnancy or lactation.
  8. Hypertensive patients with poorly controlled blood pressure (a systolic blood pressure more than 160 mmHg or a diastolic blood pressure more than 100 mmHg).
  9. Those who had taken hormones or other drugs during the previous 3 months.
  10. Acute heart, liver, kidney or blood diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Therapy groupBushen Huatan Decoction-
Control groupPlacebo-
Primary Outcome Measures
NameTimeMethod
Ovulation rate3 months

Ovulation rate in each group during the study period

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The Second Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine

🇨🇳

Nanchang, Jiangxi, China

© Copyright 2025. All Rights Reserved by MedPath